^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

SAB298

i
Other names: SAB298
News
Trials
Company:
Sabila Biosci
Drug class:
SRC-family kinase (SFK) inhibitor
News
Trials